A Multi Center Study of Sexual Toxicities After Radiotherapy
Part of paid clinical trials in Atlanta, Georgia.
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Study ID
- NCT05394428
- Status
- Recruiting
Conditions
- Malignant Neoplasms
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- No intervention — OTHERNo intervention
Study Details
The purpose of this research is to understand how radiotherapy and other cancer treatments impact sexual function in female cancer patients and to try to answer a question about why some patients who receive radiotherapy are more likely to have side effects than others. The results of this study may improve our understanding of why sexual side effects occur and in turn develop predictive models and biomarkers of sexual side effects and other side effects that may impact sexual function. The results of this study may also lead to improvements in the techniques used to deliver radiotherapy or the development of interventions that will prevent or reduce sexual side effects and improve quality of life for female patients with cancer.
Key Dates
- Start date
- Oct 4, 2022
- Status verified
- Nov 2024
- Primary completion
- Aug 31, 2026
- Completion
- Aug 31, 2026
Study Design
- Enrollment
- 300 participants (estimated)
Arms
- Arm: Patients with female sexual organs treated with pelvic radiotherapyPatients with female sexual organs treated with pelvic radiotherapy.
Primary Outcome Measure
Establish Sexual Quality of Life Cohort [ Time Frame: 2 years ]
Central Contacts
- Deborah C Marshall, MD MAS201-500-5522
- Natasha Gironimi, MPH646-984-9321
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Emory University | Atlanta | Georgia | 30322 | Mylin Torres, MD, BA (PRINCIPAL_INVESTIGATOR) |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | Deborah C Marshall, MD Natasha A Gironimi Deborah C Marshall, MD (PRINCIPAL_INVESTIGATOR) |
| M.D. Anderson Cancer Center | Houston | Texas | 77030 | Anuja Jhingran, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Atlanta, GA
Related Studies
- A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid TumorsPHASE1 · Recruiting · Pfizer · Birmingham, Alabama
- Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant DiseaseRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland